banda transcan 2 2016ul

 

Cancer is among the leading causes of death and represents a significant burden of disease worldwide. In Europe it is the most important cause of morbidity and death after cardiovascular diseases, with 3 million new cases and 1,7 million deaths each year (Globocan 2012, http://globocan.iarc.fr/). Cancer is a challenge for the public health, it can even become a chronic disease contributing substantially to the growth of medical expenditures and constituting a major socio-economic issue for Europe as well as globally. To address the increasing need at the European level, to reduce incidence and mortality of malignancies and to improve the quality of life of cancer patients, a coordinated effort is necessary. A rapid and effective bidirectional transfer of relevant cancer research findings between bench and bedside would play a pivotal role. The key area of translational cancer research addresses these needs, however, the research efforts in the field should be harmonised and integrated so as to profit from coordination at transnational level.


The ERA-NET  TRANSCAN-2 (Aligning national/regional translational cancer research programmes and activities), in continuity with the preceding ERA-NET on translational cancer research TRANSCAN, aims at linking translational cancer research funding programmes among the partners, most of which were also participants in the previous TRANSCAN project. Therefore, the network had already established a model of transnational cooperation encouraging high quality research through competitive funding, as exemplified by the successful implementation of  3 joint transnational calls in the past years. This model allows an efficient use of the dedicated national resources and the coordination of the financial management of multinational research projects aiming as much as possible at the harmonisation of administrative procedures.


TRANSCAN-2 News


Looking forward to having our 3rd and final TRANSCAN-2 symposium on Tumour Heterogeneity in Milan on October 24th!
The symposium will include talks from the funded consortia of JTC2014, co-funded by the EC, an exciting discussion on the impact and added value of transnational collaborations on cancer research and a poster prize competition for young scientists.
The event is hosted by Lombardy Region, Italy with the collaboration of Fondazione Regionale per la Ricerca Biomedica
To register follow this link .
Participation is free of charge, however registration is mandatory, as the number of seats is limited.
For further information please contact: liron.ef@moh.gov.il

 

Newsletters

Newsletter 8, May 2019

Newsletter 7, October 2018
Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, December 2017
Newsletter 3, September 2017
Newsletter 2, April 2017
Newsletter 1, December 2016

To subscribe to TRANSCAN-2 newsletter mailing list please send an email to: This email address is being protected from spambots. You need JavaScript enabled to view it.

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 7 guests and no members online